Loading...
Loading...
India's insulin imports from SWITZERLAND total $15.6M across 41 shipments from 2 foreign suppliers. ELI LILLY EXPORT S.A leads with $13.4M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for insulin — a concentrated sourcing relationship with select suppliers from SWITZERLAND.

ELI LILLY EXPORT S.A is the leading Insulin supplier from SWITZERLAND to India, with import value of $13.4M across 27 shipments. The top 5 suppliers — ELI LILLY EXPORT S.A, ELI LILLY EXPORT S.A. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ELI LILLY EXPORT S.A | $13.4M | 27 | 86.1% |
| 2 | ELI LILLY EXPORT S.A. | $2.2M | 14 | 13.9% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED | $15.6M | 41 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Insulin suppliers from SWITZERLAND to India include ELI LILLY EXPORT S.A, ELI LILLY EXPORT S.A.. The leading supplier is ELI LILLY EXPORT S.A with import value of $13.4M USD across 27 shipments. India imported Insulin worth $15.6M USD from SWITZERLAND in total across 41 shipments.
India imported Insulin worth $15.6M USD from SWITZERLAND across 41 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Insulin sourced from SWITZERLAND include ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED. The largest buyer is ELI LILLY AND COMPANY (INDIA ) PRIVATE LIMITED with $15.6M in imports across 41 shipments.
The total value of Insulin imports from SWITZERLAND to India is $15.6M USD, across 41 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
41 Verified Shipments
2 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists